Research Article

A Liver Stiffness Measurement-Based Nomogram Predicts Variceal Rebleeding in Hepatitis B-Related Cirrhosis

Table 1

Clinical characteristics of study participants. Patient characteristics.

All patients ()

Gender
 Male199 (68.86)
 Female90 (31.14)
Age (years)55.96 (13.15)
BMI (kg/m2)22 (3.07)
Hypertension27 (9.34)
Diabetes36 (12.46)
HB (g/L)99.5 (27.6)
WBC (×109/L)4.36 (2.28)
Use of NSBB189 (65.4)
PTV36 (12.46)
AST (IU/L)35 (26-52.5)
ALT (IU/L)24 (16-40.5)
Platelet count (×109/L)71 (46-121.5)
Total bilirubin (μmol/L)19.5 (12.8-29.6)
Albumin (g/L)34.7 (6.08)
ALP (IU/L)88 (62-130)
GGT (IU/L)32 (19-74)
Baseline LSM (kPa)14.25 (10.58-19.13)
PT (second)13.6 (12.6-14.8)
INR1.21 (1.11-1.33)
Fibrinogen (g/L)1.97 (1.15)
Cr (μmol/L)65.5 (55.8-77.9)
BUN (mmol/L)5.9 (5.19)
HBeAg59 (20.41)
HBV DNA (log10 IU/mL)
Portal vein diameter (cm)1.5 (1.3-1.6)
MELD score9.04 (8.126-11.17)
Child-Pugh class
 A264 (91.35)
 B25 (8.65)

Continuous variables are expressed as mean (standard deviation) or median (interquartile range); categorical variables are expressed as number (percentage). BMI: body mass index; HB: hemoglobin; WBC: white blood cell; PVT: portal vein thrombosis; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; GGT: gamma-glutamyl transpeptidase; LSM: liver stiffness measurement; INR: international normalized ratio; Cr: creatinine BUN: blood urea nitrogen; PT: prothrombin time.